Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma study

Transfusion

Volumn 56, Issue 10, 2016, Pages 2455-2465

  Fedele, Pasquale L ^a,b,d   Polizzotto, Mark N ^a,e,f   Grigoriadis, George ^a,b,c   Waters, Neil ^a,i   Comande, Mary ^a,g   Borosak, Marija ^a,h   Portbury, David ^a   Wood, Erica M ^a,b,c,i  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b Department of Haematology   (Australia)

^c SOUTHERN HEALTH   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h EASTERN HEALTH   (Australia)

ⁱ MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA;

ARTICLE; AUSTRALIA; CLINICAL ASSESSMENT; EXTRACORPOREAL OXYGENATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; PLASMA TRANSFUSION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; BLOOD BANK; BLOOD COMPONENT THERAPY; HEMATOLOGIC DISEASES; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PLASMA; PROCEDURES; QUESTIONNAIRE; STANDARDS; SURGERY; THROMBOCYTE; UTILIZATION;

BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; HEMATOLOGIC DISEASES; HUMANS; NEOPLASMS; PLANNING TECHNIQUES; PLASMA; SURGICAL PROCEDURES, OPERATIVE; SURVEYS AND QUESTIONNAIRES;

EID: 84991661497     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13778     Document Type: Article

References (23)

1. Duke WW. The relation of blood platelets to hemorrhagic disease. J Am Med Assoc 1910;55:1185.
2. Estcourt LJ. Why has demand for platelet components increased? A review. Transfus Med 2014;24:260–8.
3. Stanworth SJ, Grant-Casey J, Lowe D, et al. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011;51:62–70.
4. Glasgow SM, Allard S, Doughty H, et al. Blood and bombs: the demand and use of blood following the London Bombings of 7 July 2005—a retrospective review. Transfus Med 2012;22:244–50.
5. Shortt J, Polizzotto MN, Waters N, et al. Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use. Transfusion 2009;49:2296–303.
6. NHMRC. Clinical practice guidelines on the use of blood components. Canberra: National Health and Medical Research Council; 2002.
7. Charlton A, Wallis J, Robertson J, et al. Where did platelets go in 2012? A survey of platelet transfusion practice in the North of England. Transfus Med 2014;24:213–8.
8. Wells AW, Llewelyn CA, Casbard A, et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med 2009;19:315–28.
9. AIHW. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. Cancer Series no. 69. Cat. no. CAN 65. Canberra: Australian Institute of Health and Welfare; 2012.
10. Fedele PL, Avery S, Patil S, et al. Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia. Intern Med J 2014;44:757–63.
11. Blombery P, Kivivali L, Pepperell D, et al. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry. Intern Med J 2016;46:71–9.
12. Shah NL, Intagliata NM, Northup PG, et al. Procoagulant therapeutics in liver disease: a critique and clinical rationale. Nat Rev Gastroenterol Hepatol 2014;11:675–82.
13. Baker RI, Coughlin PB, Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181:492–7.
14. Crawford JH, Augustson BM. Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed? Med J Aust 2006;184:365–6.
15. Imberti D, Barillari G, Biasioli C, et al. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus 2011;9:148–55.
16. Tran H, Collecutt M, Whitehead S, et al. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation. Intern Med J 2011;41:337–43.
17. Tran HA, Chunilal SD, Harper PL, et al. An update of consensus guidelines for warfarin reversal. Med J Aust 2013;198:198–9.
18. Cobain TJ, Vamvakas EC, Wells A, et al. A survey of the demographics of blood use. Transfus Med 2007;17:1–15.
19. Novis DA, Renner S, Friedberg RC, et al. Quality indicators of fresh frozen plasma and platelet utilization. Arch Pathol Lab Med 2002;126:527–32.
20. ANZSBT. Extended life plasma: a framework for preparation, storage and use. 2nd ed. Sydney: Australian & New Zealand Society of Blood Transfusion Ltd; 2013.
21. ACSQHC. National safety and quality health service standards. Sydney: Australian Commission on Safety and Quality in Health Care; 2012.
22. Australian Health Ministers' conference statement on national stewardship expectations for the supply of blood and blood products. Lyneham: National Blood Authority, Australia. 2010.
23. National blood and blood product wastage reduction strategy 2013-17 [Internet]. Lyneham: National Blood Authority, Australia; 2016 [cited 2016 Mar 01]. Available from: http://blood.gov.au/wastage.